Annual Retained Earnings
-$51.56 M
-$5.80 M-12.66%
31 August 2024
Summary:
Lexaria Bioscience annual retained earnings is currently -$51.56 million, with the most recent change of -$5.80 million (-12.66%) on 31 August 2024. During the last 3 years, it has fallen by -$19.73 million (-61.99%). LEXX annual retained earnings is now -68009.34% below its all-time high of -$75.70 thousand, reached on 31 October 2005.LEXX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$51.56 M
-$2.18 M-4.42%
31 August 2024
Summary:
Lexaria Bioscience quarterly retained earnings is currently -$51.56 million, with the most recent change of -$2.18 million (-4.42%) on 31 August 2024. Over the past year, it has dropped by -$4.62 million (-9.83%). LEXX quarterly retained earnings is now -49144.29% below its all-time high of -$104.70 thousand, reached on 01 January 2006.LEXX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.7% | -9.8% |
| 3 y3 years | -62.0% | -52.4% |
| 5 y5 years | -116.0% | -108.1% |
LEXX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -62.0% | at low | -62.0% | at low |
| 5 y | 5 years | -116.0% | at low | -116.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Lexaria Bioscience Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2024 | -$51.56 M(+12.7%) | -$51.56 M(+4.4%) |
| May 2024 | - | -$49.37 M(+3.7%) |
| Feb 2024 | - | -$47.59 M(+1.4%) |
| Nov 2023 | - | -$46.94 M(+2.6%) |
| Aug 2023 | -$45.76 M(+17.0%) | -$45.76 M(+2.8%) |
| May 2023 | - | -$44.52 M(+5.6%) |
| Feb 2023 | - | -$42.15 M(+3.2%) |
| Nov 2022 | - | -$40.85 M(+4.5%) |
| Aug 2022 | -$39.10 M(+22.8%) | -$39.10 M(+3.9%) |
| May 2022 | - | -$37.63 M(+6.8%) |
| Feb 2022 | - | -$35.25 M(+4.2%) |
| Nov 2021 | - | -$33.82 M(+6.3%) |
| Aug 2021 | -$31.83 M(+14.5%) | -$31.83 M(+3.8%) |
| May 2021 | - | -$30.65 M(+9.1%) |
| Feb 2021 | - | -$28.09 M(-1.4%) |
| Nov 2020 | - | -$28.50 M(+2.5%) |
| Aug 2020 | -$27.80 M(+16.5%) | -$27.80 M(+2.6%) |
| May 2020 | - | -$27.09 M(+5.3%) |
| Feb 2020 | - | -$25.73 M(+3.8%) |
| Nov 2019 | - | -$24.78 M(+3.8%) |
| Aug 2019 | -$23.87 M(+20.7%) | -$23.87 M(+4.7%) |
| May 2019 | - | -$22.79 M(+5.4%) |
| Feb 2019 | - | -$21.62 M(+5.6%) |
| Nov 2018 | - | -$20.47 M(+3.5%) |
| Aug 2018 | -$19.77 M(+50.1%) | -$19.77 M(+6.6%) |
| May 2018 | - | -$18.55 M(+22.6%) |
| Feb 2018 | - | -$15.13 M(+10.0%) |
| Nov 2017 | - | -$13.75 M(+4.4%) |
| Aug 2017 | -$13.17 M(+16.5%) | -$13.17 M(+5.5%) |
| May 2017 | - | -$12.48 M(+2.8%) |
| Feb 2017 | - | -$12.14 M(+3.8%) |
| Nov 2016 | - | -$11.70 M(+3.5%) |
| Aug 2016 | -$11.30 M(+12.0%) | -$11.30 M(+2.9%) |
| May 2016 | - | -$10.99 M(+2.4%) |
| Feb 2016 | - | -$10.73 M(+2.5%) |
| Nov 2015 | - | -$10.47 M(+3.8%) |
| Aug 2015 | -$10.09 M | -$10.09 M(+5.4%) |
| May 2015 | - | -$9.57 M(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | -$9.10 M(+5.1%) |
| Nov 2014 | - | -$8.66 M(+39.1%) |
| Aug 2014 | -$8.32 M(+64.4%) | - |
| July 2014 | - | -$6.23 M(+10.2%) |
| Apr 2014 | - | -$5.65 M(+9.6%) |
| Jan 2014 | - | -$5.16 M(+2.0%) |
| Oct 2013 | -$5.06 M(+7.3%) | -$5.06 M(+2.6%) |
| July 2013 | - | -$4.93 M(+1.2%) |
| Apr 2013 | - | -$4.87 M(+1.0%) |
| Jan 2013 | - | -$4.83 M(+2.4%) |
| Oct 2012 | -$4.71 M(+5.6%) | -$4.71 M(-0.7%) |
| July 2012 | - | -$4.75 M(-1.4%) |
| Apr 2012 | - | -$4.81 M(+5.1%) |
| Jan 2012 | - | -$4.58 M(+2.7%) |
| Oct 2011 | -$4.46 M(+13.7%) | -$4.46 M(-0.0%) |
| July 2011 | - | -$4.46 M(+6.0%) |
| Apr 2011 | - | -$4.21 M(+3.8%) |
| Jan 2011 | - | -$4.05 M(+3.3%) |
| Oct 2010 | -$3.92 M(+16.4%) | -$3.92 M(+2.0%) |
| July 2010 | - | -$3.85 M(+0.8%) |
| Apr 2010 | - | -$3.82 M(+4.4%) |
| Jan 2010 | - | -$3.65 M(+8.4%) |
| Oct 2009 | -$3.37 M(+28.8%) | -$3.37 M(+5.3%) |
| July 2009 | - | -$3.20 M(+7.0%) |
| Apr 2009 | - | -$2.99 M(+7.7%) |
| Jan 2009 | - | -$2.78 M(+6.2%) |
| Oct 2008 | -$2.62 M(+59.7%) | -$2.62 M(+13.9%) |
| July 2008 | - | -$2.30 M(+2.6%) |
| Apr 2008 | - | -$2.24 M(+31.3%) |
| Jan 2008 | - | -$1.71 M(+4.0%) |
| Oct 2007 | -$1.64 M(+180.8%) | -$1.64 M(-30.1%) |
| July 2007 | - | -$2.35 M(+94.3%) |
| Apr 2007 | - | -$1.21 M(+44.3%) |
| Jan 2007 | - | -$837.10 K(+43.3%) |
| Oct 2006 | -$584.00 K(+671.5%) | -$584.00 K(+225.2%) |
| July 2006 | - | -$179.60 K(+33.4%) |
| Apr 2006 | - | -$134.60 K(+28.6%) |
| Jan 2006 | - | -$104.70 K |
| Oct 2005 | -$75.70 K | - |
FAQ
- What is Lexaria Bioscience annual retained earnings?
- What is the all time high annual retained earnings for Lexaria Bioscience?
- What is Lexaria Bioscience annual retained earnings year-on-year change?
- What is Lexaria Bioscience quarterly retained earnings?
- What is the all time high quarterly retained earnings for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly retained earnings year-on-year change?
What is Lexaria Bioscience annual retained earnings?
The current annual retained earnings of LEXX is -$51.56 M
What is the all time high annual retained earnings for Lexaria Bioscience?
Lexaria Bioscience all-time high annual retained earnings is -$75.70 K
What is Lexaria Bioscience annual retained earnings year-on-year change?
Over the past year, LEXX annual retained earnings has changed by -$5.80 M (-12.66%)
What is Lexaria Bioscience quarterly retained earnings?
The current quarterly retained earnings of LEXX is -$51.56 M
What is the all time high quarterly retained earnings for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly retained earnings is -$104.70 K
What is Lexaria Bioscience quarterly retained earnings year-on-year change?
Over the past year, LEXX quarterly retained earnings has changed by -$4.62 M (-9.83%)